A Life-Course Approach to Vaccination Can Drive Healthy Aging

As life spans increase and birth-rates decrease, the world’s population is aging. From 2000 to 2025, the over-60 demographic segment will double from 600 million to almost 1.2 billion. By 2050, it will nearly double again, surpassing two billion and accounting for an incredible 22% of the total global population. A society this “old” has never before existed, and it is a social, ethical, and economic imperative to keep older adults healthy and engaged. It is timely for the global public health community to re-align its thinking, policies and activities to this new demographic reality.

Organizations at national and global levels have begun to pursue initiatives to promote healthy aging, and these efforts are going to intensify in the coming years. Thus far, the progress has been admirable, with the World Health Organization, the United Nations, the Organisation for Economic Co-operation and Development, and others taking leadership roles. Yet, despite many promising developments, the potential of “life-course immunization,” which stresses the administration of vaccines throughout all stages of life – including for adults – to prevent disease and promote health, has been largely overlooked, especially among adults.

Benefits of Immunizations in Adults

As adults age, they increase their risk of contracting vaccine-preventable diseases like pneumococcal disease, herpes zoster (shingles), and influenza, among others. Immunization in the adult years – and throughout the life-course – enables adults to age with reduced risk to such vaccine-preventable diseases. Disease-free, older adults can remain active, healthy participants in society while curtailing increases in healthcare expenses and more fully engaging in economic life.

  • Professor of Global Ageing, University of Stirling, Scotland
  • Marjorie Coote Professor of Health Care for Older People,
    University of Sheffield
  • Founder, Sheffield Institute for Studies on Ageing (Winner
    of 2000 Queen’s Anniversary Prize)

The on-line geriatric assessment can be combined with different courses. The price of the courses ranges from 40 CHF to 1000 CHF depending on the level of desired training. The progressive model with the digital assessment tool which Geneva-based company calls Respond 4.0 is supposed to reduce health costs. The papi-boomer phenomenon, coupled with medical care sometimes too prompt to hospitalize, costs a lot to public authorities, who pay more than half of the hospital bill.

There is a wealth of evidence to suggest the health and economic benefits of influenza vaccination in adult populations.”

—GCoA Founder Michael Hodin

Similar research could and should also be done for other vaccine-preventable diseases – like herpes zoster (shingles), influenza, and hepatitis B – that older adults run increased risk of contracting. As we discuss below, this should be a major policy priority for policymakers and other stakeholders. Furthermore, with this data supporting the public health benefits of various adult immunizations, new vaccine innovations would be incentivized and, eventually, brought to market. This is also how childhood immunizations were developed, and the model of success should be brought to innovations in adult vaccines.

Remaining Obstacles

For all of the potential of life-course immunization programs, there do remain a number of barriers to implementation. Research by the Alliance for Health and the Future shows that, globally, the causes for the lack of uptake of life-course vaccination programs include complex vaccination schedules and inadequate physician knowledge. Patients, too, have limited awareness of the benefits of vaccinations for themselves and their families. There is a lack of vaccination recommendation alignment among national and global bodies, and this, in part, prevents patients from complying with recommendations.

Part of the problem is ideological.  Embedded attitudes about vaccines would shift with increased understanding of their value as adult immunization becomes a central part of public health thinking. Throughout the industrialized world, it is common for people to get vaccines before they travel abroad in order to prevent disease, but they do not consider the disease risks they face while at home. In the developing world, there is often lack of awareness and resources. As we have seen over the past few decades with childhood vaccinations, access is only part of the equation. The other part is raising awareness and understanding of how vaccines can improve health. The GAVI Alliance has done a tremendous job of creating an appreciation for children’s vaccines in the developing world. A similar level of attention needs to be placed on the critical value of adult vaccines as the global population ages.

Policy Priorities to Promote Life-Course Immunization

A life-course approach to immunization can only become a reality for people around the world with the dedication of and coordinated follow-through by policymakers. The most essential first steps are:

  • Increase awareness regarding the health benefits of life-course immunization among health professionals, as well as employers, employee groups, and unions; to be led by local and national governments, as well as global organizations like the World Health Organization;
  • Establish or enhance existing surveillance systems to determine the burden of vaccine-preventable diseases in adults; to be accomplished through partnership between national and global bodies;
  • Create institutional alignment on adult vaccination schedules among leading organizations like the World Health Organization, the Centers for Disease Control and Prevention, the European Union, the Pan American Health Organization, and others willing to participate
  • Integrate adult immunizations into Personal Medical Records and create an adult immunization registry; to be accomplished through partnership between private and public organizations;
  • Integrate adult vaccination in public and private payer access programs;
  • Embed adult vaccination in core preventive services for adults; advocacy to be led by both public and private organizations with a stake in cost containment and improved health outcomes;
  • Bring adult immunization into global public health as a matter of course in our 21st century; led, for example, by the World Health Organization and other multi-governmental organizations and NGOs.

Over the last couple of years, health and aging experts have made significant strides in rolling out plans for healthy aging initiatives. From President Obama’s pledge to end Alzheimer’s by 2025 to the United Nations’ historic summit on non-communicable diseases, national and global health leaders have pioneered new paths for healthy aging. Conspicuously missing from these efforts is a campaign for life-course immunization. Policymakers around the world should put life-course immunization at the top of their agenda in order to enable healthy aging and support social and economic success in the 21st century.

Source: Health Affairs

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

What Old Age Might Be Like for Today’s 30-Year-Olds

Get ready for a new old age. With the U.S. fertility rate in a decadelong slump and the life expectancy of 65-year-old Americans approaching roughly 85, our aging nation is likely to grow older by midcentury, as the ratio of young to old continues to decline. The trend is likely to upend how our society is organized, making life very different for today’s 30-year-olds when they reach their 60s compared with life for 60-year-olds now.

World Population Reaches 8bn As It Grows Older

The world’s population reached 8bn people on Tuesday and will hit 9bn in 15 years as it experiences an unprecedented surge in the number of older people, according to the latest UN data. The global fertility rate has more than halved since the 1950s to 2.3 births per woman. With mortality also falling, the number of people aged 65 and over is expected to rise from 783mn in 2022 to 1bn by 2030 and reach 1.4bn by 2043, the UN population data revealed.

Global Coalition on Aging (GCOA) Launches Cross-Sector Alliance Committed to Health Innovation at High-Level Forum on The Silver Economy

Today, the Global Coalition on Aging (GCOA), along with cross-sector stakeholders representing patient advocacy, policy, industry, and academic communities, announced the launch of the Alliance for Health Innovation at the High-Level Forum on the Silver Economy in New York. The Alliance is dedicated to establishing the importance of innovation in achieving healthy aging and health equity through investments, policy reforms, and strategic partnerships.

Japan Must Face Up to Growing Danger of Drug-resistant Germs

In the wake of more than 6.4 million COVID-19 deaths worldwide and unprecedented economic destruction, the global community has no excuse to be caught unprepared for the next pandemic. Yet right now, a devastating parallel plague is already underway and worsening. Some years, it is killing well over 1 million people, according to medical journal The Lancet.

A Bipartisan Bill Could Prevent The Next Pandemic

In Washington, Republicans and Democrats are typically at loggerheads when it comes to healthcare policy. Just consider the recent Inflation Reduction Act, which made extensive changes to Medicare and also extended Affordable Care Act subsidies. Every single congressional Democrat voted for the legislation, while every single member of the GOP voted against it. But occasionally, a bill is such an obviously good idea, and so desperately needed, that it commands significant bipartisan support. The PASTEUR Act, co-sponsored by 31 Democrats and 31 Republicans in the House and two members of each party in the Senate, is just such a bill.

Korea Must Act Now to Combat Growing AMR Threat

Public officials are overlooking one of the gravest long-term threats to the Korean people, the health system, and economy: antimicrobial resistance (AMR). Some pathogens ― bacteria, fungi, parasites, and viruses ― have evolved strains that resist the antimicrobial medications we currently have available to fight them. Health care professionals often must watch helplessly as patients succumb to infections that antibiotics could once have easily beaten. They know that new antimicrobials, including and especially antibiotics, could easily gain the victory ― but they have none at their disposal.

Policy Statement on the Impact of Price Negotiations on Innovation, Healthy Aging and Equity

As the CEO of the Global Coalition on Aging (GCOA) and a newly formed cross-sector Alliance for Health Innovation, we write to express our deep concern with the current legislation that allows for price “negotiations” in Medicare – a thinly veiled signal for America’s plunge into price controls that will have a devastating and adverse impact on biopharmaceutical innovation and our nations’ ability to support healthy aging.